Liverpool ChiroChem: Funding, Investors & Team (Oct 2026)
Liverpool ChiroChem (LCC) is a chemistry-based CRO that produces chiral small molecules for biotech/pharmaceutical R&D. Their specialist products can be used as building blocks, fragments and screening compounds to enable small molecule drug discovery. their chemical technologies provide efficient access to novel chiral building blocks for hit identification and hit-to-lead optimization. LCC’s catalytic methods give access to a wide range of chiral amines in excellent enantiomeric purity. Their initial focus is on the production and supply of chiral piperidines and other sp3-rich nitrogen heterocycles , which are of great importance to drug discovery and development due to their excellent pharmacokinetic properties e.g. improved solubility and bioavailability. LCC's technologies were developed through years of research in the areas of asymmetric hydrogenation and Pd-coupling. LCC now provide collaborate services with their customers to optimise key steps in synthetic routes.
Liverpool ChiroChem has raised $2.8M across 1 funding round on record, the most recent an undisclosed round of $2.8M announced in Apr 2021.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Liverpool ChiroChem Company Profile and Key Stats
Latest funding round on record: Apr 2021.
Liverpool ChiroChem Funding Rounds
Liverpool ChiroChem Founders and Leadership Team
Contact details for the Liverpool ChiroChem team: 1 of 1 has an email address on file.
Start 14-day free trial →Liverpool ChiroChem Funding Compared to Other Biotechnology Startups
Liverpool ChiroChem's latest round of $2.8M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Liverpool ChiroChem in Biotechnology and Liverpool
Companies Similar to Liverpool ChiroChem
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
Liverpool ChiroChem Funding FAQs
What does Liverpool ChiroChem do?
Liverpool ChiroChem (LCC) is a chemistry-based CRO that produces chiral small molecules for biotech/pharmaceutical R&D. Their specialist products can be used as building blocks, fragments and screening compounds to enable small molecule drug discovery. their chemical technologies provide efficient access to novel chiral building blocks for hit identification and hit-to-lead optimization. LCC’s catalytic methods give access to a wide range of chiral amines in excellent enantiomeric purity. Their initial focus is on the production and supply of chiral piperidines and other sp3-rich nitrogen heterocycles , which are of great importance to drug discovery and development due to their excellent pharmacokinetic properties e.g. improved solubility and bioavailability. LCC's technologies were developed through years of research in the areas of asymmetric hydrogenation and Pd-coupling. LCC now provide collaborate services with their customers to optimise key steps in synthetic routes.
How much funding has Liverpool ChiroChem raised?
Liverpool ChiroChem has raised $2.8M across 1 round on record. The most recent is an undisclosed round of $2.8M announced in Apr 2021.
When did Liverpool ChiroChem last raise funding?
Liverpool ChiroChem's most recent funding round on record is an undisclosed round of $2.8M, announced in Apr 2021.
Who is the CEO of Liverpool ChiroChem?
Paul Colbon is listed as CEO at Liverpool ChiroChem.
Where is Liverpool ChiroChem headquartered?
Liverpool ChiroChem is based in Liverpool, United Kingdom.
How many employees does Liverpool ChiroChem have?
Liverpool ChiroChem is in the 11-50 employee band.
How does Liverpool ChiroChem's funding compare to other Biotechnology startups?
Liverpool ChiroChem's latest round of $2.8M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Liverpool ChiroChem Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Liverpool ChiroChem is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.